Delivery Order SPE2DR25D6028-SPE2DR26FARFB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,360.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector sets on October 27, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The contract utilizes no set-aside provisions and represents a child order under AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $5,569.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a $3,853.56 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This firm fixed-price contract, with an ultimate completion date of September 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $23,293.20 delivery order on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,795.27 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of August 12, 2025, represents a competitively awarded delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,927.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This non-set-aside, competitively awarded contract is classified as a Delivery Order under a Firm Fixed Price arrangement, with an ultimate completion date of September 10, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.04 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed price, competitively awarded delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARFBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $23,085.46 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3mg auto-injectors on November 3, 2025, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under a larger indefinite delivery contract vehicle. This delivery order is issued under AmerisourceBergen's primary indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, coupled with its extensive portfolio of pharmaceutical product deliveries, positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 11/3/25 |